Center/Research Area Affiliations
Dr. Comander’s research interests include understanding the molecular basis of retinal degenerations, such as retinitis pigmentosa, and pursuing therapies for these disorders. He has published studies on the natural history of retinitis pigmentosa and other retinal disorders. Currently, he developing new techniques to speed characterization of potentially-disease causing DNA variants, testing gene therapy techniques in primates, and is an investigator and surgeon for a number of ongoing clinical trials for patients with inherited retinal disorders.
For a full publication list, please see his CV.
Course of Ocular Function in PRPF31 Retinitis Pigmentosa
. Hafler BP, Comander J
, Weigel DiFranco C, Place EM, Pierce EA. Semin Ophthalmol
Efficient In Silico Identification of a Common Insertion in the MAK Gene which Causes Retinitis Pigmentosa. Bujakowska KM, White J, Place E, Consugar M, Comander J. PLoS One. 2015 Nov 11;10(11):e0142614.
Visual Function in Carriers of X-Linked Retinitis Pigmentosa. Comander J, Weigel-DiFranco C, Sandberg MA, Berson EL. Ophthalmology. 2015 Sep;122(9):1899-906.
Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment
. Mantopoulos D, Murakami Y, Comander J, Thanos A, Roh M, Miller JW, Vavvas DG. PLoS One
. 2011; 6(9):e24245.
Diagnostic testing and disease monitoring in birdshot chorioretinopathy. Comander J, Loewenstein J, Sobrin L. Semin Ophthalmol. 2011 Jul-Sep; 26(4-5): 329-36.
View a list of publications on pubmed.gov »